Meitav Investment House’s CME Group CME Stock Holding History

Meitav Investment House’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.99M	Sell	9,013 -3,896	-30%	-$1.08M	0.01%	192
2026 Q1	$3.81M	Hold	12,909	–	–	0.04%	103
2025 Q4	$3.53M	Hold	12,909	–	–	0.04%	107
2025 Q3	$3.49M	Sell	12,909 -1,576	-11%	-$429K	0.05%	104
2025 Q2	$3.99M	Buy	14,485 +11,136	+333%	+$3.03M	0.05%	98
2025 Q1	$884K	Buy	+3,349	New	+$826K	0.02%	145
2020 Q3	–	Sell	-111,601	Closed	-$18.1M	–	405
2020 Q2	$18.1M	Buy	111,601 +5,349	+5%	+$959K	1.09%	38
2020 Q1	$18.4M	Buy	106,252 +56,718	+115%	+$11.3M	1.37%	21
2019 Q4	$9.97M	Buy	49,534 +48,578	+5,081%	+$9.97M	0.72%	32
2019 Q3	$204K	Sell	956 -238	-20%	-$49.7K	0.01%	413
2019 Q2	$232K	Buy	+1,194	New	+$220K	0.02%	380
2019 Q1	–	Sell	-4,624	Closed	-$863K	–	395
2018 Q4	$863K	Buy	4,624 +620	+15%	+$114K	0.05%	164
2018 Q3	$693K	Buy	4,004 +391	+11%	+$65.8K	0.03%	246
2018 Q2	$590K	Buy	3,613 +170	+5%	+$27.8K	0.03%	306
2018 Q1	$547K	Buy	+3,443	New	+$548K	0.03%	249

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Meitav Investment House's CME Position: Q2 2026 in Review

Meitav Investment House reduced its CME Group (CME) stake by 30% in Q2 2026, selling an estimated $1.08M and leaving 9,013 shares worth $1.99M. The position accounts for 0.01% of the portfolio, ranked #192.

Meitav Investment House first reported a position in CME in Q1 2018 and has held it in 15 quarters since. The position peaked at $18.4M in Q1 2020. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Meitav Investment House held 9,013 shares of CME Group worth $1.99M as of Q2 2026.
Meitav Investment House sold 3,896 CME Group shares in Q2 2026, an estimated $1.08M.
CME Group made up 0.01% of Meitav Investment House's portfolio in Q2 2026, its #192 holding.
Meitav Investment House first reported a position in CME Group in Q1 2018 and has held it in 15 quarters since.
Meitav Investment House's CME Group position peaked at $18.4M in Q1 2020.
1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Meitav Investment House's 13F filing for Q2 2026, filed 20 Jul 2026.